T. Spelman Et Al. , "Comparative efficacy of first line natalizumab versus IFNb or glatiramer acetate in relapsing MS," 31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS , 2015
Spelman, T. Et Al. 2015. Comparative efficacy of first line natalizumab versus IFNb or glatiramer acetate in relapsing MS. 31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS .
Spelman, T., Kalincik, T., Jokubaitis, V., Zhang, A., Pelligrini, F., Wiendl, H., ... Belachew, S.(2015). Comparative efficacy of first line natalizumab versus IFNb or glatiramer acetate in relapsing MS . 31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS
Spelman, Tim Et Al. "Comparative efficacy of first line natalizumab versus IFNb or glatiramer acetate in relapsing MS," 31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS, 2015
Spelman, Tim Et Al. "Comparative efficacy of first line natalizumab versus IFNb or glatiramer acetate in relapsing MS." 31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS , 2015
Spelman, T. Et Al. (2015) . "Comparative efficacy of first line natalizumab versus IFNb or glatiramer acetate in relapsing MS." 31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS .
@conferencepaper{conferencepaper, author={Tim Spelman Et Al. }, title={Comparative efficacy of first line natalizumab versus IFNb or glatiramer acetate in relapsing MS}, congress name={31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS}, city={}, country={}, year={2015}}